Prof. SALİH AKSU

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Postoperative bleeding adversely affects total knee arthroplasty outcomes in hemophilia

Göker B., Çağlar Ö., Kınıklı G. İ., Aksu S., Tokgözoğlu A. M., Atilla B.

Knee, vol.39, pp.261-268, 2022 (SCI-Expanded)

Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)

Kaynar L., Tekgunduz E., KOZANOĞLU İ., Ozkan H. A., AKSU S., ÖZKALEMKAŞ F., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.61, no.1, 2022 (SCI-Expanded)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.52, no.2, pp.413-419, 2022 (SCI-Expanded)

Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.32, no.1, pp.65-67, 2022 (SCI-Expanded)

Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.

BMJ SUPPORTIVE & PALLIATIVE CARE, 2021 (SCI-Expanded) Sustainable Development

Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

Goren Sahin D., Akay O. M., KEKLİK M., Okan V., KARAKUŞ A., Demir C., et al.

ANNALS OF HEMATOLOGY, vol.100, pp.1667-1675, 2021 (SCI-Expanded)

Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia

ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.60, no.2, 2021 (SCI-Expanded)

Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.

CARDIOVASCULAR TOXICOLOGY, vol.21, no.3, pp.216-223, 2021 (SCI-Expanded)

Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, no.3, pp.147-153, 2021 (SCI-Expanded)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.38, no.1, pp.33-40, 2021 (SCI-Expanded)

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.

Transfusion and Apheresis Science, vol.59, no.5, 2020 (SCI-Expanded)

Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor Case report and review of the literature

ŞAHİN T. K., ALADAĞ KARAKULAK E., Setterzade E., SAİN GÜVEN G., HAZNEDAROĞLU İ. C., AKSU S.

MEDICINE, vol.99, no.26, 2020 (SCI-Expanded)

Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.2, 2020 (SCI-Expanded)

Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.1, 2020 (SCI-Expanded)

FUNCTIONAL STATUS AND FEAR OF MOVEMENT LEVELS OF HEMOPHILIA A PATIENTS FOLLOWING TOTAL KNEE ARTHROPLASTY

BOZGEYİK S., KINIKLI G. İ., AKSU S., ATİLLA B., Guney-Deniz H.

HAEMOPHILIA, vol.26, pp.171, 2020 (SCI-Expanded)

The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy

Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, vol.42, no.1, pp.17-21, 2020 (SCI-Expanded)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.4, pp.256-262, 2020 (SCI-Expanded)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.2, pp.116-120, 2020 (SCI-Expanded)

Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, no.11, pp.729-734, 2019 (SCI-Expanded)

SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA

ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.

AMERICAN JOURNAL OF HEMATOLOGY, vol.94, 2019 (SCI-Expanded)

Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., Gokei H.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, no.5, 2019 (SCI-Expanded)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

Ghasemi M., OKAY M., TÜRK S., Naeemaee R., Guver E., Malkan Ü. Y., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, vol.20, no.2, 2019 (SCI-Expanded)

The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.

GHASEMİ m., OKAY M., TÜRK S., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., et al.

Journal Of The Renin-Angiotensin-Aldosterone System, 2019 (SCI-Expanded)

Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, no.3, pp.177-182, 2019 (SCI-Expanded)

Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE, vol.14, no.1, pp.491-496, 2019 (SCI-Expanded)

Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia

Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.29, no.1, pp.14-21, 2019 (SCI-Expanded)

Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.5, pp.1560-1563, 2019 (SCI-Expanded)

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

Turk C., OKAY M., TÜRK S., Temirci E. S., Javad O., AKSU S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.2, pp.661-674, 2019 (SCI-Expanded)

The factors affecting early death in newly diagnosed APL patients

Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE, vol.14, no.1, pp.647-652, 2019 (SCI-Expanded)

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study

Ciftciler R., AKSU S., Dikmenoglu Falkmarken N., Celalettin Haznedaroglu I.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.1, pp.356-360, 2019 (SCI-Expanded)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.4, pp.985-992, 2019 (SCI-Expanded)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study

Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.36, no.2, pp.88-96, 2019 (SCI-Expanded)

Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.57, no.6, pp.752-755, 2018 (SCI-Expanded)

Combination of novoseven and feiba in hemophiliac patients with inhibitors

Malkan Ü. Y., AKSU S.

OPEN MEDICINE, vol.13, no.1, pp.618-621, 2018 (SCI-Expanded)

Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.28, no.4, pp.254-260, 2018 (SCI-Expanded)

The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.

LEUKEMIA & LYMPHOMA, vol.58, pp.96, 2017 (SCI-Expanded)

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.34, no.1, pp.103-104, 2017 (SCI-Expanded)

Bell s palsy as an early manifestation of acute lymphoblastic leukemia

ÖZÇAKAR L., AKINCI TAN F. A., ÖZGÖÇMEN S., AKSU S., ERG Ç.

Annals Of Hematology, 2017 (SCI-Expanded)

The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.4, pp.281-285, 2016 (SCI-Expanded)

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.12-19, 2016 (SCI-Expanded)

The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.3, pp.153-158, 2016 (SCI-Expanded)

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.4, pp.286-292, 2016 (SCI-Expanded)

The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.54-60, 2016 (SCI-Expanded)

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.2, pp.119-126, 2016 (SCI-Expanded)

High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology

BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY, vol.102, no.2, pp.211-217, 2015 (SCI-Expanded)

Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia

ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.

HEMATOLOGY, vol.20, no.7, pp.392-396, 2015 (SCI-Expanded)

The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.8, no.12, pp.22564-22569, 2015 (SCI-Expanded)

Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.25, no.4, pp.215-221, 2015 (SCI-Expanded)

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.32, no.2, pp.163-167, 2015 (SCI-Expanded)

Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.8, no.12, pp.22515-22519, 2015 (SCI-Expanded)

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.

ACTA HAEMATOLOGICA, vol.134, no.1, pp.32-37, 2015 (SCI-Expanded)

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.

BLOOD, vol.124, no.21, 2014 (SCI-Expanded)

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.

BLOOD, vol.124, no.21, 2014 (SCI-Expanded) Sustainable Development

Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.31, no.2, pp.136-142, 2014 (SCI-Expanded)

Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)

AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.4, pp.253-259, 2014 (SCI-Expanded)

Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population

Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.190-194, 2014 (SCI-Expanded)

An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.213-216, 2014 (SCI-Expanded)

Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report

MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.4, pp.286-288, 2014 (SCI-Expanded)

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience

GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.49, no.3, pp.590-599, 2013 (SCI-Expanded)

Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.30, no.4, pp.400-404, 2013 (SCI-Expanded)

Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, vol.14, no.4, pp.308-314, 2013 (SCI-Expanded)

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.30, no.3, pp.328-330, 2013 (SCI-Expanded)

EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.

HEMATOLOGY, vol.18, no.5, pp.247-252, 2013 (SCI-Expanded)

Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.19, no.3, pp.338-340, 2013 (SCI-Expanded)

Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.

ACTA HAEMATOLOGICA, vol.130, no.3, pp.199-205, 2013 (SCI-Expanded)

Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.4, pp.264-268, 2013 (SCI-Expanded)

Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.4, pp.260-263, 2013 (SCI-Expanded)

How do we collect better granulocyte?

Akyol T. K., Buyukasik Y., Aksu S., Ozcebe O. I.

TRANSFUSION AND APHERESIS SCIENCE, vol.47, no.1, pp.107-111, 2012 (SCI-Expanded)

Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient

UZ B., Ozdemir E., Aksu S., AKYOL T. K., JONES R.

TURKISH JOURNAL OF HEMATOLOGY, vol.29, no.2, pp.199-200, 2012 (SCI-Expanded)

Discovering Blood Donor Arrival Patterns Using Data Mining: A Method to Investigate Service Quality at Blood Centers

TESTİK M. C., OZKAYA B., AKSU S., ÖZCEBE O. İ.

JOURNAL OF MEDICAL SYSTEMS, vol.36, no.2, pp.579-594, 2012 (SCI-Expanded)

Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.46-50, 2012 (SCI-Expanded)

Histopathological Alterations in the Kidney Tissue Following Topical Ankaferd Hemostat Application in a Rat Renal Injury Model

KARAKOÇ D., Akar E., AKSU S., ÜNER A., ÖZDEMİR A., HAMALOĞLU E., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.4, pp.275-281, 2012 (SCI-Expanded)

The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia

AKSU S., ŞAHİN F., Uz B., Yavuz S. A., Atay H., KELKİTLİ E., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.8-14, 2012 (SCI-Expanded)

Striking Promotion of the In Vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat

Albayrak M., AKSU S., Celebi H., Albayrak A., Ginis Z., Yagci S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.15-22, 2012 (SCI-Expanded)

Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.1-7, 2012 (SCI-Expanded)

Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.28, no.3, pp.223-227, 2011 (SCI-Expanded)

Naturally acquired hepatitis A antibodies after haematopoetic stem cell transplantation

YALÇIN S. S., Kondolot M., GÖKER H., KUŞKONMAZ B. B., Karacan Y., ÇETİN M., et al.

EPIDEMIOLOGY AND INFECTION, vol.139, no.5, pp.683-687, 2011 (SCI-Expanded) Sustainable Development

Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, vol.8, no.1, pp.30-38, 2011 (SCI-Expanded)

Determination of burnout levels of nurses working in stem cell transplantation units in Turkey

AKKUŞ Y., Karacan Y., GÖKER H., AKSU S.

NURSING & HEALTH SCIENCES, vol.12, no.4, pp.444-449, 2010 (SCI-Expanded)

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

LEUKEMIA RESEARCH, vol.34, no.12, 2010 (SCI-Expanded)

Serological response to influenza vaccine after hematopoetic stem cell transplantation

YALÇIN Ş., Kondolot M., Albayrak N., Altas A. B., Karacan Y., Kuskonmaz B. B., et al.

ANNALS OF HEMATOLOGY, vol.89, no.9, pp.913-918, 2010 (SCI-Expanded) Sustainable Development

Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas

Beyazit Y., Kekilli M., Purnak T., GÖKER H., AKSU S., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.96-102, 2010 (SCI-Expanded)

Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis

Kurt M., Akdogan M., Onal I. K., Kekilli M., Arhan M., Shorbagi A., et al.

DIGESTIVE AND LIVER DISEASE, vol.42, no.3, pp.196-199, 2010 (SCI-Expanded)

The adhesion molecules of L-selectin and ICAM-1 in thrombocytosis and thrombocytopenia

Ulger Z., AKSU S., Aksoy D. Y., KÖKSAL D., HAZNEDAROĞLU İ. C., Kirazi S.

PLATELETS, vol.21, no.1, pp.49-52, 2010 (SCI-Expanded)

Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

INTERNAL MEDICINE, vol.49, no.22, pp.2493-2497, 2010 (SCI-Expanded)

The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.25-26, 2010 (SCI-Expanded)

Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.13-16, 2010 (SCI-Expanded)

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

ANNALS OF HEMATOLOGY, vol.88, no.7, pp.667-671, 2009 (SCI-Expanded)

In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract

Akkoc N., AKÇELİK M., HAZNEDAROĞLU İ. C., GÖKER H., Turgut M., AKSU S., et al.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.29, no.2, pp.410-415, 2009 (SCI-Expanded)

Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.

ANNALS OF HEMATOLOGY, vol.87, no.10, pp.853-854, 2008 (SCI-Expanded)

Endoscopic application of Ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: A case report

Kurt M., Disibeyaz S., Akdogan M., Sasmaz N., AKSU S., HAZNEDAROĞLU İ. C.

AMERICAN JOURNAL OF GASTROENTEROLOGY, vol.103, no.8, pp.2156-2158, 2008 (SCI-Expanded)

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.100, no.1, pp.86-90, 2008 (SCI-Expanded)

Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency

Kurt M., Shorbagi A., Aksu S., Haznedaroglu I., Altundag K., Erkin G.

BLOOD COAGULATION & FIBRINOLYSIS, vol.18, no.8, pp.805-806, 2007 (SCI-Expanded)

Renin-angiotensin system expression in the K562 human erythroleukaemic cell line

Koca E., Haznedaroglu I. C., Acar K., Beyazit Y., Aksu S., Misirlioglu M., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, vol.8, no.3, pp.145-147, 2007 (SCI-Expanded)

Alterations in the 'local umbilical cord blood renin-angiotensin system' during pre-eclampsia

Acar K., Beyazit Y., Sucak A., Haznedaroglu I. C., Aksu S., Tuncer S., et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, vol.86, no.10, pp.1193-1199, 2007 (SCI-Expanded) Sustainable Development

Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML

Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.

LEUKEMIA & LYMPHOMA, vol.47, no.5, pp.891-896, 2006 (SCI-Expanded)

Couda equina syndrome as a rare manifestation of leukemia relapse during postallograft period

Önal I. K., Shorbagi A., GÖKER H., Büyükasyk Y., ÖZÇAKAR L., Tufan A., et al.

Journal of the National Medical Association, vol.98, no.5, pp.808-810, 2006 (SCI-Expanded)

Unilateral diaphragm paralysis possibly due to cervical spine involvement in multiple myeloma

Kara M., Isik M., Ozcakar L., Erol O., Dogan S., Altundag K., et al.

MEDICAL PRINCIPLES AND PRACTICE, vol.15, no.3, pp.242-244, 2006 (SCI-Expanded)

Articles Published in Other Journals

Comprehensive Assessment of Common Medical Problems in Adult Patients with Hemophilia A: A Single-Center Experience in Turkey

Aydin M. S., Ciftciler R., İNKAYA A. Ç., AKSU S.

GAZI MEDICAL JOURNAL, vol.33, no.1, pp.1-4, 2022 (ESCI)

Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

KEKLİK KARADAĞ F., Yenerel M. N., YILMAZ M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., Tuglular T. F., et al.

AMERICAN JOURNAL OF BLOOD RESEARCH, vol.11, no.3, pp.279-285, 2021 (ESCI)

Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

HEMATOLOGY REPORTS, vol.12, no.1, 2020 (ESCI)

Effects of Smoking on Hematological Parameters and Ferritin Levels

Ciftciler R., Guven A., HAZNEDAROĞLU İ. C., AKSU S.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol.57, no.4, pp.372-376, 2019 (ESCI)

CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY

BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.

Genetics and Application, vol.3, no.1, pp.51-56, 2019 (Peer-Reviewed Journal)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

TÜRK TÜRK S., Malkan Ü. Y., Ghasemi M., Hocaoglu H., Mutlu D., Gunes G., et al.

SAGE OPEN MEDICINE, vol.5, 2017 (ESCI)

THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.74, no.1, pp.7-12, 2011 (ESCI)

Inappropiate Fresh Frozen Plasma use in Coagulation Disorders

AKKAŞ M., ataman d. k., AKMAN C., METİN AKSU N., KARACA M. A., AKSU S., et al.

European Journal of Surgical Sciences, vol.2, no.2, pp.38-41, 2011 (Peer-Reviewed Journal)

Inappropriate Fresh Frozen Plasma Use in Coagulation Disorder

AKKAŞ M., KÖMÜR ATAMAN D., AKMAN C., METİN AKSU N., KARACA M. A., AKSU S., et al.

European Journal of Surgical Sciences, vol.2, pp.38-41, 2011 (Peer-Reviewed Journal)

Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report

Ozdemir D., DAĞDELEN S., Erbas T., AĞBAHT K., Serefhanoglu S., AKSU S., et al.

CASE REPORTS IN MEDICINE, 2010 (ESCI)

DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.73, no.3, pp.74-79, 2010 (ESCI)

Refereed Congress / Symposium Publications in Proceedings

FUNCTIONAL STATUS AND FEAR OF MOVEMENT LEVELS OF HEMOPHILIA A PATIENTS FOLLOWING TOTAL KNEE ARTHROPLASTY

BOZGEYİK S., KINIKLI G. İ., AKSU S., ATİLLA B., GÜNEY DENİZ H.

EAHAD2020/NETHERLANDS, The Hague, Netherlands, 5 - 07 February 2020

Abstracts

BOZGEYİK S., KINIKLI G. İ., AKSU S., ATİLLA B., GÜNEY DENİZ H.

EAHAD2020, The Hague, Netherlands, 03 February 2020, vol.26

THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE

SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.

15th International Conference on Malignant Lymphoma, Switzerland, 18 - 22 June 2019, vol.37, pp.366

ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.

4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019

ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.

4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019

MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.

3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Turkey, 8 - 09 March 2019

Alt Ekstremite Artropatisi Olan ve Olmayan Hemofilik Bireylerin Yaşam Kalitesi, Depresyon ve Anksiyete Seviyelerinin Karşılaştırılması

AYKAR S., CAN F., AKSU S.

28. Ulusal Türk Ortopedi ve Travmatoloji Kongresi, Turkey, 30 October - 04 November 2018

Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132

LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.191-192

MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.266

LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018

DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.364-365 Sustainable Development

AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.261

Descriptive analysis of myeloproliferative diseases and its complications

OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73

RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Turkey, 18 - 22 September 2018

RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Cyprus (Kktc), 20 - 22 September 2018

AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.

4.İLAÇ VE TEDAVİ KONGRESİ, Cyprus (Kktc), 19 - 23 September 2018, pp.254

EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

The International Congress of BMT 2018, Busan, South Korea, 30 August - 01 September 2018

PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.

2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018

KINESIOPHOBIA, QUALITY OF LIFE, DEPRESSION AND ANXIETY LEVEL IN ADULT HEMOPHILIAC PATIENTS: A CONTROLLED STUDY

AYKAR S., CAN F., AKSU S.

EAHAD 2018, 7 - 09 February 2018, vol.24, pp.32-135

Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation

KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H., ŞAHİNER M. L., OKAY M., AYDIN M. S., et al.

59th ASH, 9 - 12 December 2017, vol.130, pp.5521

Donor Lymphocyte Infusions: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.

LYMPHOMAMYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.48

Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.

LYMPHOMA AND MYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.43-44

Donor Lymhocyte Infusion: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.

LYMHOMA MYELOMA 2017, 26 - 28 October 2017

Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.

LYMPHOMA MYELOMA 2017, 26 - 28 October 2017

EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.

INTERNATIONAL CONGRESS OF BMT 2018, Busan, South Korea, 30 August - 01 September 2018, vol.53

Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.

malkan Ü. Y., DEMİROĞLU H., AKSU S., HAZNEDAROĞLU İ. C., SAYINALP N.

XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Germany, 08 July 2017 - 13 January 2018, vol.1, pp.402

The Impact of Chemo/Immune Therapy-‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.

iwcll2017, New York, United States Of America, 12 - 15 May 2017

Ayak Bileği Burkulması Olan Bir Hemofili Hastasında Kuvvetlendirme Egzersizleri, Manuel Tedavi ve Proprioseptif Eğitimin Ağrı, Ayak Fonksiyonları ve Hareket Korkusuna Olan Etkisi.

ÖNAL S., CAN F., AKSU S.

14. Türkiye Hemofili Kongresi, Turkey, 12 - 15 April 2017